Navigation Links
Scientists Spot Source of Hurdle to AIDS Vaccine
Date:12/18/2009

Immune system turns off antibodies that could block HIV, study finds

FRIDAY, Dec. 18 (HealthDay News) -- Researchers have identified the cause of a major hurdle in efforts to develop an AIDs vaccine.

In tests with mice, the scientists found that the immune system can produce B cells with the potential to make powerful antibodies against HIV, the virus that causes AIDS. But the immune system mistakenly perceives these cells as harmful and destroys them before they have a chance to mature.

The study was published in this week's online issue of the Proceedings of the National Academy of Sciences.

"This work may mean that we need to think and act very differently in envisioning how a successful vaccine may work," study author Laurent Verkoczy, an assistant professor of medicine at Duke University Medical Center, said in a news release from the school.

"The good news is that while about 85 percent of the 'right' kind of B cells are eliminated, about 15 percent survive and wind up in circulating blood, but are turned off. One goal in vaccine design may be to figure out how to wake them up so they can go to work," Verkoczy explained.

The researchers plan to conduct mouse studies to test ways to teach the immune system to allow production of antibodies that can block HIV.

More information

The U.S. Department of Health and Human Services has more about AIDS vaccines.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Dec. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. BioProcess International Launches a New and Improved Website for Biopharmaceutical Managers and Scientists
2. Scientists Link Molecule to Severe Swine Flu
3. Scientists use cell phone records to predict spread of malaria
4. Scientists uncover protective mechanism against liver cancer
5. UNC scientists coordinate study of link between insulin use and cancer in people with diabetes
6. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
7. NeuroFocus Adds Two More of the Worlds Leading Neuroscientists to its Advisory Board
8. Scripps Research scientists reveal key structure from ebola virus
9. Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists
10. Caltech scientists show how ubiquitin chains are added to cell-cycle proteins
11. Vanderbilt scientists report first effective medical therapy for rare stomach disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: